Wendell David Associates Inc. increased its stake in shares of Danaher Corporation (NYSE:DHR) by 4.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,500 shares of the conglomerate’s stock after buying an additional 2,755 shares during the period. Danaher Corporation comprises about 1.1% of Wendell David Associates Inc.’s investment portfolio, making the stock its 27th largest position. Wendell David Associates Inc.’s holdings in Danaher Corporation were worth $5,865,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Louisiana State Employees Retirement System raised its stake in shares of Danaher Corporation by 1.1% in the second quarter. Louisiana State Employees Retirement System now owns 37,900 shares of the conglomerate’s stock valued at $3,198,000 after buying an additional 400 shares during the last quarter. LS Investment Advisors LLC raised its stake in shares of Danaher Corporation by 1.3% in the second quarter. LS Investment Advisors LLC now owns 189,695 shares of the conglomerate’s stock valued at $16,008,000 after buying an additional 2,512 shares during the last quarter. Hudson Valley Investment Advisors Inc. ADV increased its position in Danaher Corporation by 24.4% in the second quarter. Hudson Valley Investment Advisors Inc. ADV now owns 8,255 shares of the conglomerate’s stock valued at $697,000 after buying an additional 1,620 shares during the period. Watch Point Trust Co increased its position in Danaher Corporation by 2.6% in the second quarter. Watch Point Trust Co now owns 19,427 shares of the conglomerate’s stock valued at $1,640,000 after buying an additional 495 shares during the period. Finally, CWM LLC increased its position in Danaher Corporation by 1.8% in the second quarter. CWM LLC now owns 3,467 shares of the conglomerate’s stock valued at $293,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 76.56% of the company’s stock.
Danaher Corporation (NYSE:DHR) opened at 79.82 on Friday. The stock has a market cap of $55.45 billion, a price-to-earnings ratio of 25.48 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01. The firm has a 50-day moving average price of $82.89 and a 200-day moving average price of $84.21.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. Danaher Corporation’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the business posted $0.90 EPS. Equities research analysts expect that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Wendell David Associates Inc. Buys 2,755 Shares of Danaher Corporation (DHR)” was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://www.com-unik.info/2017/08/12/wendell-david-associates-inc-raises-position-in-danaher-corporation-dhr-updated-updated.html.
DHR has been the topic of several analyst reports. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Saturday, July 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Cowen and Company reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Sunday, April 23rd. Finally, William Blair reaffirmed an “outperform” rating on shares of Danaher Corporation in a research note on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. Danaher Corporation currently has an average rating of “Buy” and an average target price of $91.76.
In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the transaction, the director now directly owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock valued at $3,206,426 in the last three months. 12.20% of the stock is currently owned by company insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
What are top analysts saying about Danaher Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Danaher Corporation and related companies.